Concepedia
Statistics
Publications
52
Citations
3.8K
H-Index
29
Active since
1980
Affiliations
Hebrew University of Jerusalem(Current)
Hadassah Medical Center
Weizmann Institute of Science
Jewish General Hospital
St. Jude Children's Research Hospital
Shulamit Katzav is an author at Hebrew University of Jerusalem specializing in medicine, cell biology, and immunology.
Top concepts
MedicineCell BiologyImmunologyTumor BiologyNatural SciencesCancer BiologyMolecular BiologyCell SignalingGene ExpressionSignal Transduction
Publications per year
1980–2020
vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.
Shulamit Katzav, Dionisio Martín‐Zanca, Mariano Barbacid · The EMBO Journal · 1989 · 516 citations
Hematopoietic Cells, Hematology, Blood Cell +5
Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection
Reinhard Wallich, Nadja Bulbuc, Günter J. Hämmerling et al. · Nature · 1985 · 409 citations
Tumor Biology, Cancer Immunosurveillance, Novo Expression +8
Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
Ben Margolis, Patrick J Hu, Shulamit Katzav et al. · Nature · 1992 · 359 citations
Tyrosine Phosphorylation, Transcriptional Regulation, Viral Replication +11
Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations.
Giuseppe Cimino, Donald T. Moir, Ora Canaani et al. · PubMed · 1991 · 183 citations
Cytogenetics, Mixed-phenotype Acute Leukemia, Genetics +16
A Functional T-Cell Receptor Signaling Pathway Is Required for p95<sup><i>vav</i></sup> Activity
Jun Wu, Shulamit Katzav, Arthur J. Weiss · Molecular and Cellular Biology · 1995 · 170 citations · Full text
Adaptive Immune System, T-regulatory Cell, Immune Regulation +21
1–5 of 52